News
The leadership change comes at the end of a week in which the California-based toymaker landed squarely in the crosshairs of ...
Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...
Kenvue Inc. (NYSE: KVUE), today announced the appointment of Amit Banati as the Company’s Chief Financial Officer, effective ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...
Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.
(Reuters) -Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday, as strong demand for its self ...
The stock's rise snapped a three-day losing streak.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
This was the stock's third consecutive day of losses.
19h
Benzinga on MSNNeutrogena-Maker Kenvue Beats Profit Forecast, Ups Sales OutlookKenvue reported first-quarter sales of $3.74 billion, topping the $3.68 billion consensus, according to Benzinga. Total sales ...
The Neutrogena and Aveeno owner has also increased its 2025 full-year outlook to reflect the impact of costs associated with ...
Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSofya Tsinis - Head of Investor RelationsThibaut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results